Scotland has been failed by the current model of devolution. In retrospect, the rhetoric of Holyrood's driving spirits looks ...
Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced positive topline results from the US Phase 3 ConfIdeS trial of imlifidase, evaluating 12-month kidney function ...
Novel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly ...
The Anchorage Fire Department received the 2025 Secretary of Defense Employer Support Freedom Award at a ceremony at the ...
Throughout the long market changes, GAC Toyota has consistently upheld its values. For this company, respecting user choices ...
Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with evidence to ...